Proceedings of 36th AGM held on 24.09.2025 through VC/OAVM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd held its 36th Annual General Meeting on Wednesday, September 24, 2025, via video conferencing from 11:00 AM to 11:30 AM. Three ordinary resolutions were passed with the required majority through a combination of remote e-voting (held September 21-23, 2025) and venue voting. The resolutions covered: (1) adoption of the standalone and consolidated audited financial statements for FY ended March 31, 2025, (2) reappointment of Mr. Mansoor Abdul Vahab (DIN: 02882381), who retires by rotation, and (3) appointment of Ms. Riddhi Shah, Practising Company Secretary, as the Secretarial Auditor. Mrs. Riddhi Shah also served as the scrutinizer for both the e-voting and venue voting processes. Notably, the filing is signed by Adarsh Munjal as Whole-Time Director 'For Remedium Lifecare Limited', which suggests the company may have undergone a name change or rebranding that investors should verify.
All resolutions were routine governance items that passed without issue, so there is no direct share-price catalyst from this filing. Investors should, however, clarify the Supha Pharmachem / Remedium Lifecare naming discrepancy, as it may reflect a corporate restructuring or rebrand that could have future implications.